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Abstract
Background: From an early age, humans look longer at preferred stimuli and also typically look longer at facial
expressions of emotion, particularly happy faces. Atypical gaze patterns towards social stimuli are common in
autism spectrum conditions (ASC). However, it is unknown whether gaze fixation patterns have any genetic basis.
In this study, we tested whether variations in the cannabinoid receptor 1 (CNR1) gene are associated with gaze
duration towards happy faces. This gene was selected because CNR1 is a key component of the endocannabinoid
system, which is involved in processing reward, and in our previous functional magnetic resonance imaging (fMRI)
study, we found that variations in CNR1 modulate the striatal response to happy (but not disgust) faces. The
striatum is involved in guiding gaze to rewarding aspects of a visual scene. We aimed to validate and extend this
result in another sample using a different technique (gaze tracking).
Methods: A total of 30 volunteers (13 males and 17 females) from the general population observed dynamic
emotional expressions on a screen while their eye movements were recorded. They were genotyped for the
identical four single-nucleotide polymorphisms (SNPs) in the CNR1 gene tested in our earlier fMRI study.
Results: Two SNPs (rs806377 and rs806380) were associated with differential gaze duration for happy (but not
disgust) faces. Importantly, the allelic groups associated with a greater striatal response to happy faces in the fMRI
study were associated with longer gaze duration at happy faces.
Conclusions: These results suggest that CNR1 variations modulate the striatal function that underlies the
perception of signals of social reward, such as happy faces. This suggests that CNR1 is a key element in the
molecular architecture of perception of certain basic emotions. This may have implications for understanding
neurodevelopmental conditions marked by atypical eye contact and facial emotion processing, such as ASC.
Background
Vision is the primary sensory modality in primates,
reflected by the visual cortex being the largest of all the
sensory cortices. Our eyes perform quick orienting
movements (’saccades’) towards interesting features of
stimuli in the external world [1]. In general, we tend to
look longer at more rewarding stimuli [2]. This rationale
lies behind the ‘preferential looking’ technique in infancy
research, where gaze duration and direction are assumed
to reflect visual preference [2-6]. Gaze not only informs
us about normative variation in the visual processing of
stimuli but also is relevant to the understanding of com-
plex neurodevelopmental conditions such as autism
spectrum conditions (ASC), which are characterised by
atypical gaze fixation patterns [7,8]. This has led to the
suggestion that gaze fixation patterns could constitute
potential endophenotypes for such conditions. Gaze pat-
terns show high test-retest reliability as well as a moder-
ate to high heritability when tested in twins [9-11],
suggesting a significant genetic contribution. This raises
the possibility that variation in candidate genes underlie
normative variation in gaze patterns.
The measure of particular interest to us is the dura-
tion of gaze fixation, given the evidence that people with
ASC show reduced gaze fixation towards social stimuli
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[8,12-15]. Research in primates suggests that the striatal
region plays a major role in directing gaze [16]. The
striatum is thought to encode a ‘value map’ of the visual
stimuli. Both ventral striatal neurons as well as a subpo-
pulation of caudate neurons encode reward magnitude
of the stimuli [17,18]. This ‘value map’, in addition to
further frontal cortical inputs, is then passed to the lat-
eral intraparietal area (LIP), where a fine-tuned map of
‘relative expected subjective value’ is created. The LIP
projects to the frontal eye fields, which send excitatory
projections to the caudate nucleus. A subset of neurons
from the caudate nucleus inhibit the substantia nigra
and consequently disinhibit the superior colliculus,
which in turn controls the gaze control nuclei in the
brainstem, leading to a gaze shift [19].
One of the key molecular systems involved in the func-
tioning of the striatal circuit is the endocannabinoid sys-
tem. It is a neuropeptidergic circuit involved in reward
processing and works in tandem with the mesolimbic
dopaminergic system [20]. Expressed selectively in the
brain, the cannabinoid receptor 1 (CNR1) is the best-stu-
died molecule of this system. Immunolocalisation studies
in rats and humans have indicated high CNR1 expression
levels in the striatum, a region known for its central role
in reward processing [20-24]. CNR1 is believed to modu-
late striatal dopamine release through a trans-synaptic
mechanism involving both GABAergic and glutamatergic
synapses and is expressed strongly in the caudate, puta-
men, globus pallidus internal and substantia nigra, as
well as in the shell of the nucleus accumbens [25]. Phasic
release of striatal dopamine is the primary mechanism
encoding for reward [26].
Recent studies have suggested abnormalities in ASC in
striatal volume [27,28], connectivity [29] and activity in
response to social stimuli [30]. In addition, a gene
expression study of postmortem brain tissue of people
with ASC found reduced expression of CNR1 [31]. In
view of the atypical gaze behaviour of people with ASC,
together with the observed striatal atypicalities, it is rea-
sonable to examine the phenotype of gaze patterns as a
function of variation in genes expressed in the striatum.
As gaze fixation is linked to striatal activity [16,17,19],
we might expect that molecular variation in the genes
involved in striatal function would be associated with
differences in gaze towards socially rewarding stimuli.
Using functional magnetic resonance imaging (fMRI),
we previously found genetic variation in CNR1 modu-
lated activity in the striatal region while watching happy
(but not disgust) faces [32]. This result has been inde-
pendently replicated in larger samples [33]. In the cur-
rent study, we aimed to conduct an identical experiment
using gaze-tracking in a new sample of volunteers. Spe-
cifically, we tested whether CNR1 genetic variation influ-
ences gaze duration towards happy faces. To ensure that
this was closely matched to the original fMRI experi-
ment, we also analysed gaze fixation duration for disgust
expressions as a function of CNR1 genetic variation.
Disgust faces are potential signals of ‘nonreward’, in
contrast to rewarding happy faces, and hence provide a
high-level control condition (that is, matched for face-
specific qualities, such as configural features, as well as
more general visual qualities of the stimuli, such as col-
our, shape and luminosity) for our experiment. We pre-
dicted that variation (single-nucleotide polymorphisms
(SNPs)) in the CNR1 gene would be significantly asso-
ciated with individual variability in gaze duration
towards happy but not disgust faces.
Methods
Participants
A total of 30 student volunteers (13 males and 17
females; 29 right-handed and 1 left-handed; mean age ±
SD, 24.1 ± 3.41 years old) were recruited by advertise-
ment from the local universities. Participants were
included only if all four grandparents were of Caucasian
European ancestry to avoid genetic heterogeneity
between different populations. Participants were also
excluded if they reported any history of psychiatric diag-
noses or regular drug abuse. They were equated for edu-
cational background in that all had completed high
school and were studying towards a college degree. All
had normal (or corrected to normal) vision. The study
was approved by the Psychology Research Ethics Com-
mittee of the University of Cambridge.
Buccal swabs were collected from all participants, and
DNA was extracted. The four SNPs of choice were iden-
tical to those selected in our earlier fMRI study
(rs1049353, rs806377, rs806380 and rs6454674), chosen
to ensure a minor allele frequency > 0.2 in a Caucasian
population and to cover as much of the gene as possible
(see Figure 1) [32]. The DNA was genotyped by Gene-
service, Inc. (Cambridge, UK) using standard TaqMan™
assays (Applied Biosystems, Inc., California, USA). Gen-
otyping for these SNPs failed for two of these partici-
pants, resulting in a sample size of 28 participants for
the final analysis.
Procedure
The stimuli were taken from the Mindreading™ set
developed by Baron-Cohen et al. [34], since dynamic
facial expressions of emotion are assumed to be more
ecologically valid than static photographs. The Mind-
reading set consists of video, audio and textual examples
for 412 different emotions arranged into 24 emotion
groups and organised according to six different develop-
mental levels (based on emotions recognised in child-
hood through adulthood). These stimuli have been
validated in typical populations and in people with ASC
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[35-38]. These stimuli were chosen over other existing
available stimuli because Mindreading stimuli comprise
dynamic emotional expressions whilst alternatives (such
as the Ekman and Friesen set [39], the Karolinska Direc-
ted Emotional Faces set [40] and the NimStim set [41])
comprise static expressions. The Mindreading stimuli
have excellent interrater reliability and external validity
[36,38] (stimuli are available at http://www.jkp.com/
mindreading/).
Participants were seated comfortably at a fixed dis-
tance of 60 cm from the screen and were instructed to
keep movement to a minimum. Participants watched 80
videoclips (three seconds each and sixteen clips for each
of the five emotions) presented in a pseudorandom
order using GazeTracker™ software (DynaVox Inc., Vir-
ginia, USA) with an interstimulus interval of six seconds.
Participants were shown a fixation cross during the
interstimulus interval. All stimuli were centred on a 19-
inch monitor and occupied 70% of the screen area. To
ensure that participants were attending to the stimulus,
they were asked to say aloud what emotion they thought
was being displayed (choosing one of five emotion
words: ‘happy’, ‘sad’, ‘angry’, ‘disgust’ or ‘fear’). Their
responses were recorded by the experimenter.
The Eye Response Interface Computer Aid camera
(ERICA; http://www.eyeresponse.com/) was used to
measure fixation time at each point at 60 Hz. ERICA
uses reflected low-frequency infrared rays (l = 880 nm)
to map macrosaccades and fixation times at each point.
The data were preprocessed using GazeTracker™ soft-
ware. To ensure that the measured gaze duration was
specific to the socially informative regions of the emotion
expressions [35], ‘look zones’ were manually drawn
around the eyes (the eyebrows and lower eyelids) and
mouth region (the region from the bottom of the nose to
the bottom of the lower lip) of all stimuli (see Figure 2).
All look zones were ‘dynamic’; that is, they tracked the
eyes and the mouth regions while allowing for head
movement of the actors.
The sum of duration of all fixations was recorded for
each look zone. A fixation was defined as a continuous
gaze for 100 ms within a 40-pixel diameter (correspond-
ing to a 1.3° visual angle), which was in line with para-
meters used in similar studies [15]. Gaze duration for
each expression was calculated by summing the mean
fixation time for eyes and mouth regions. Different
regions of the face (that is, eyes and mouth) are relevant
for processing different basic emotions [12,42-44]. Thus
it is not ideal to compare the fixation time to the eyes
region for happy and disgust faces, since disgust faces
are associated with greater gaze duration to the mouth
region. Hence, total fixation time across eyes and mouth
regions was used as the dependent variable.
Results
Both happy and disgust expressions were recognised
with > 80% accuracy. Genetic association was measured
using the UNPHASED programme (http://www.mrc-
bsu.cam.ac.uk/personal/frank/software/unphased), which
computes the retrospective likelihood, that is, the
probability of observing different genotypes given an
observed distribution of a quantitative trait [45]. The
two dependent variables (gaze duration for all happy
and all disgust faces) and the genotypes for all four
SNPs were included in a single analysis. This analysis
revealed a significant association of the gaze duration
for happy faces with rs806377 (c2 = 8.88, df = 2, P =
0.011) and rs806380 (c2 = 8.46, df = 2, P = 0.014). No
significant associations (at P ≤ 0.05) were noted for
gaze duration for disgust faces (nominal prs806377 =
0.104 and nominal prs806380 = 0.086). To test whether
the observed lack of significant association with disgust
faces was due to one video clip that was misclassified
by a majority of the participants, the data were reana-
lysed after removing all fixation data associated with
this one video clip. This revealed an identical pattern
of results, with a nominal prs806377 = 0.111 and a nom-
inal prs806380 = 0.105.
However, when multiple SNPs are in linkage disequili-
brium (LD), hypothesis tests in single-locus analyses are
not independent. To take this into account, Li and Ji



Figure 1 Schematic structure of the cannabinoid receptor
CNR1 gene with all four genotyped single-nucleotide
polymorphisms indicated. Top: White boxes indicate untranslated
regions, black boxes indicate translated regions and intervening
straight line indicates an intronic region. Bottom: The linkage
disequilibrium structure of the gene in the Caucasian (CEU)
population is shown (using the publicly available HapMap version 3,
release R2, database available at http://hapmap.ncbi.nlm.nih.gov/.
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[46] proposed a method for estimating the true number
of independent tests (Meff), which takes into considera-
tion the LD between SNPs. This method was implemen-
ted using the SNPSpD software programme [47], which
revealed that Meff was 3 in the current sample. The
Bonferroni correction for three independent tests gave a
corrected P = 0.033 for rs806377 and a corrected P = of
0.042 for rs806380 for association with gaze duration for
happy faces.
To further analyse genotypic differences for each SNP
that were significantly associated with gaze duration for
happy faces, post hoc t-tests were conducted. In
rs806377, the CC genotype was associated with longer
gaze duration than the CT genotype (t = 2.92, P < 0.025
with the Bonferroni correction). In rs806380, the GG
genotype was associated with longer gaze duration than
the AA genotype (t = 2.78, P < 0.05 with the Bonferroni
correction) (see Figure 2).
The main effects of all possible haplotypes were tested
with various possible window sizes (two, three and four
marker combinations) using UNPHASED software.
None of these haplotypic association tests were signifi-
cant at P < 0.05. While the small sample size did not
allow for a robust test of sex differences in this genetic
association, we report the nominal P values for these
tests for the sake of completeness. rs806377 was
significantly associated with the gaze duration for happy
faces in both females (P = 0.021) and males (P = 0.004).
Additionally, in males, rs806380 (P = 0.019) and
rs1049353 (P = 0.004) were found to be associated with
gaze duration for happy faces.
Discussion
In this experiment, we predicted that CNR1 genetic var-
iations would be associated with differences in gaze fixa-
tion duration towards happy faces. This prediction was
confirmed: two SNPs in this gene (rs806377 and
rs806380) were associated with differences in gaze dura-
tion for happy (but not disgust) faces. This finding fits
well with the established role of the CNR1 gene in
reward processes [20] and is consistent with the results
of fMRI studies [32,33] in showing that this gene is a
component of the molecular architecture of social
reward processing. Social reward processing has been
suggested to be impaired in people with ASC [48-50],
particularly as reflected in atypical gaze patterns towards
social stimuli. Hence the current results could be rele-
vant to understanding the genetic underpinning of the
social behavioural symptoms in people with ASC.
A comparison of these results with those from our
earlier fMRI study reveals that for the SNP rs806377,
the allelic group (CC) associated with the highest striatal
Figure 2 Example gaze trail from a single participant and group mean gaze durations for happy faces classified by genotype. (a)
Example gaze trail from a single participant on a still frame from a video stimulus showing a happy expression. The black circles represent
fixation points and the amount of time (in seconds) spent in each. The dotted lines demarcate each look zone (eyes region and mouth region).
(b) Gaze duration for happy faces grouped by genotype for rs806380 (top) and rs806377 (bottom), respectively. Unfilled circles indicate mean
gaze duration, and error bars represent ± 1 SEM. From the Mindreading™ set developed by Baron-Cohen et al. [34]
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response is also associated with the longest gaze dura-
tion for happy faces. For rs806380, the allelic group
associated with the highest striatal response (GG) is also
associated with the longest gaze duration for happy
faces. rs806377 is located in an untranslated region
(UTR) of the gene (Figure 1), and rs806380 was found
to be in significant LD with a 5’-UTR SNP (rs78074274)
using CandiSNPer [51]. The observed effects can thus
be mediated by either or both of these UTR SNPs by
potentially altering gene transcription and/or mRNA
stability. Since the fMRI and gaze duration data come
from largely independent samples (only three of thirty
participants were common to both studies), it is likely
that the observed genetic differences reflect real effects.
We interpret the genetically linked biasing of visual
perception in terms of individual differences in the
reward circuitry. The two processes of increased visual
preference (indicated by longer gaze duration) and
increased striatal response for happy faces are linked in
a positive feedback loop [5]. We tend to look longer at
preferred stimuli, which in turn increases our prefer-
ence/’reward value’ for these stimuli. Consequently, we
interpret the observed effect in biasing visual perception
of social stimuli in terms of differences in the individual
reward circuitry. Whether such intrinsic differences in
reward circuitry change the formation and nature of
‘saliency/value maps’ formed during gaze fixation is a
question for future research [19,52].
A second broader question for future research is
whether the observed CNR1 genotypic differences in
fixation duration for happy faces is specific to social
rewards or whether this holds true for all classes of
rewards. Variation in CNR1 has been linked to polysub-
stance abuse and associated with increased activity in
reward-processing areas of the brain in response to
drug cues for both marijuana and alcohol addicts
[53,54]. Hence it is possible that the observed genoty-
pic differences in the general population may extend
to other classes of rewards. Crucially, however, a
reduced experience of rewards in response to social
stimuli such as happy faces (as has been suggested by
Dawson et al. [48] to apply to ASC) has more far-
reaching consequences, since if an infant is looking
less at happy faces and is finding them less rewarding,
this will make social interactions less reinforcing,
which in turn can exacerbate the social difficulties
observed in people with ASC.
It is possible that a number of genes, each of small to
medium effect size, determine the striatal response to
social stimuli such as happy faces. Other potential can-
didate genes might include those involved in the oxyto-
cin-vasopressin system (OXTR, AVPR1A and AVPR1B)
as well as those coding for key proteins involved in neu-
trotransmission (for example, MAOA and GABRB3)
[55]. We speculate that these genes have an additive
effect and might potentially underlie complex traits
related to social functioning [56]. In a larger population-
based genetic association study of empathy, we found a
nominally significant association of CNR1 genetic varia-
tion with the Empathy Quotient [55,57]. Additionally,
reduced expression of CNR1 was found in postmortem
brain tissue of individuals with ASC [31]. Together,
these findings further support the implication that varia-
tion in the CNR1 gene modulates the response to social
stimuli such as happy faces.
However, the current findings should be interpreted
with caution, since, in the absence of any expression
data, any functional role for the SNPs can only be spec-
ulative; that is, the observed SNP effects may be caused
by being in LD with other functional polymorphisms
and/or through mechanisms that affect mRNA stability
or splicing as mentioned earlier. However, the observa-
tion of genetic differences in two separate (albeit small)
samples using an identical paradigm with two different
techniques points towards a putative role played by
CNR1 in the response to happy faces.
Conclusions
In this study, we tested whether common variants in the
CNR1 gene modulate gaze duration towards happy
faces. We found that two SNPs in this gene were signifi-
cantly associated with gaze duration for happy (but not
disgust) faces. This result is consistent with that of our
previous fMRI study [32]. Specifically, the allelic groups
that were found to be associated with the strongest
striatal response in our fMRI study were associated with
the longest gaze duration for happy faces in the current
sample. This finding suggests a role for CNR1 in social
reward processing and could have significance for clini-
cal conditions such ASC, which are marked by a deficit
in social reward processing as well as atypical responses
to facial expressions of emotion [35,36,49].
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